JP2022551753A5 - - Google Patents
Info
- Publication number
- JP2022551753A5 JP2022551753A5 JP2022522648A JP2022522648A JP2022551753A5 JP 2022551753 A5 JP2022551753 A5 JP 2022551753A5 JP 2022522648 A JP2022522648 A JP 2022522648A JP 2022522648 A JP2022522648 A JP 2022522648A JP 2022551753 A5 JP2022551753 A5 JP 2022551753A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- item
- construct
- retrovirus
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962916095P | 2019-10-16 | 2019-10-16 | |
| US62/916,095 | 2019-10-16 | ||
| PCT/US2020/056130 WO2021076998A1 (en) | 2019-10-16 | 2020-10-16 | Producer viruses for generation of retroviruses in situ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022551753A JP2022551753A (ja) | 2022-12-13 |
| JP2022551753A5 true JP2022551753A5 (https=) | 2023-09-15 |
Family
ID=75538385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022522648A Ceased JP2022551753A (ja) | 2019-10-16 | 2020-10-16 | レトロウイルスをｉｎ ｓｉｔｕで生成させるための生産者ウイルス |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220220505A1 (https=) |
| EP (1) | EP4051302A4 (https=) |
| JP (1) | JP2022551753A (https=) |
| KR (1) | KR20220082033A (https=) |
| CN (1) | CN114901297A (https=) |
| AU (1) | AU2020366460A1 (https=) |
| CA (1) | CA3151982A1 (https=) |
| WO (1) | WO2021076998A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3125020A1 (en) * | 2019-01-07 | 2020-07-16 | Kalivir Immunotherapeutics, Inc. | Methods of treating cancer |
| US20250369012A1 (en) * | 2022-06-21 | 2025-12-04 | Skyline Therapeutics Limited | Recombinant aav for the gene therapy of sma disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA68327C2 (en) * | 1995-07-04 | 2004-08-16 | Gsf Forschungszentrum Fur Unwe | A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals |
| AT406376B (de) * | 1998-01-16 | 2000-04-25 | Immuno Ag | Chimäres poxvirus enthaltend eine retrovirale vektorkomponente |
| US20060057553A1 (en) * | 2000-05-30 | 2006-03-16 | Estuardo Aguilar-Cordova | Chimeric viral vectors for gene therapy |
| ATE437221T1 (de) * | 2001-05-14 | 2009-08-15 | Gbp Ip Llc | Lentivirale vektoren kodierend für gerinnungsfaktoren für die gentherapie |
| GB0702695D0 (en) * | 2007-02-12 | 2007-03-21 | Ark Therapeutics Ltd | Production of vectors |
| GB201322798D0 (en) * | 2013-12-20 | 2014-02-05 | Oxford Biomedica Ltd | Production system |
| KR20180133395A (ko) * | 2016-02-25 | 2018-12-14 | 메모리얼 슬로안 케터링 캔서 센터 | 암 면역요법을 위한, 인간 flt3l 또는 gm-csf의 발현이 있거나 없으며 티미딘 키나제가 결실된 복제 가능 약독화 백시니아 바이러스 |
| CA3070146A1 (en) * | 2016-07-19 | 2018-01-25 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Oncolytic viruses targeting stat3 |
-
2020
- 2020-10-16 AU AU2020366460A patent/AU2020366460A1/en not_active Abandoned
- 2020-10-16 WO PCT/US2020/056130 patent/WO2021076998A1/en not_active Ceased
- 2020-10-16 CA CA3151982A patent/CA3151982A1/en active Pending
- 2020-10-16 CN CN202080087854.1A patent/CN114901297A/zh active Pending
- 2020-10-16 KR KR1020227015954A patent/KR20220082033A/ko not_active Ceased
- 2020-10-16 EP EP20876064.5A patent/EP4051302A4/en active Pending
- 2020-10-16 JP JP2022522648A patent/JP2022551753A/ja not_active Ceased
-
2022
- 2022-03-24 US US17/703,094 patent/US20220220505A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mangeot et al. | Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells | |
| Carroll et al. | Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model | |
| Follenzi et al. | Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors | |
| JP2023012463A5 (https=) | ||
| Guo et al. | Vaccinia as a vector for gene delivery | |
| JP2022163182A5 (https=) | ||
| JP4024830B2 (ja) | Ｈｈｖ−７由来の組換ウイルスベクター、その製造方法、それを用いた宿主細胞の形質転換方法、それにより形質転換された宿主細胞およびそれを用いた遺伝子治療方法 | |
| JP2008545406A5 (https=) | ||
| NO315454B1 (no) | Anvendelse av en replikasjonsdefektiv adenovirus for fremstilling av antitumormedikamenter mot dårlig vaskulariserte tumorer | |
| KR102173189B1 (ko) | 아데노 바이러스 생산 세포주 및 이의 제조방법 | |
| AU2017405929A1 (en) | Programmable oncolytic virus vaccine system and application thereof | |
| Strayer et al. | Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells | |
| CN103314107A (zh) | 具有重组的基因表达调控序列的肿瘤特异性表达得到改善的基因运载体 | |
| JP2022551753A5 (https=) | ||
| JP2007082562A (ja) | 医薬的および診断的使用のための組み換えフオーミーウイルスベクター、および組み換えフオーミーウイルスベクターの作製方法 | |
| CN101160055A (zh) | 慢病毒载体及其用途 | |
| US11732012B2 (en) | Attenuated strains of oncolytic rhabdovirus and uses thereof in tumor treatment | |
| He et al. | Recombinant lentivector as a genetic immunization vehicle for antitumor immunity | |
| KR20160140075A (ko) | 폭스바이러스 유래 프로모터 및 이를 포함하는 벡터 | |
| EP1676590A1 (en) | Oncogene therapeutic drug | |
| CN109419818B (zh) | 一种用于治疗肿瘤的埃可病毒 | |
| EP4001404A1 (en) | Virus and tumor therapeutic drug for specifically killing tumor cells | |
| CN116790675A (zh) | 一种重组慢病毒载体及其在哺乳动物t细胞中的应用 | |
| CN120647771A (zh) | 一种激活免疫细胞杀伤肿瘤细胞的融合蛋白及其重组病毒和用途 | |
| WO2025194263A1 (en) | Engineered cells for virus production |